TFR Capital’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86M Sell
118,086
-1,047
-0.9% -$25.3K 0.81% 34
2026
Q1
$2.89M Buy
119,133
+44,415
+59% +$1.08M 0.89% 30
2025
Q4
$1.81M Buy
74,718
+45,603
+157% +$1.11M 0.6% 50
2025
Q3
$709K Buy
29,115
+13,208
+83% +$320K 0.24% 85
2025
Q2
$386K Buy
+15,907
New +$384K 0.14% 119

Other funds holding IBDS

TFR Capital's IBDS Position: Q2 2026 in Review

TFR Capital reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 0.88% in Q2 2026, selling an estimated $25.3K and leaving 118,086 shares worth $2.86M. The position accounts for 0.81% of the portfolio, ranked #34.

TFR Capital first reported a position in IBDS in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.89M in Q1 2026. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • TFR Capital held 118,086 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $2.86M as of Q2 2026.
  • TFR Capital sold 1,047 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $25.3K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.81% of TFR Capital's portfolio in Q2 2026, its #34 holding.
  • TFR Capital first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • TFR Capital's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $2.89M in Q1 2026.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on TFR Capital's 13F filing for Q2 2026, filed 6 Aug 2026.